Editas Medicine, Inc. (0IFK.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 07:05PM BST. Market open.
| Previous close | 5.01 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 5,909 |
| Market cap | 2.68M |
| Beta (5Y monthly) | 2.08 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.73 |
| Earnings date | 31 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyEditas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript May 8, 2024 Editas Medicine, Inc. misses on earnings expectations. Reported EPS is $-0.76 EPS, expectations were $-0.63. Editas Medicine, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
ZacksEditas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Editas (EDIT) reports weaker-than-expected first-quarter 2024 results as both earnings and revenues fall shy of estimates. Shares fall.
Simply Wall St.Editas Medicine First Quarter 2024 Earnings: Misses Expectations
Editas Medicine ( NASDAQ:EDIT ) First Quarter 2024 Results Key Financial Results Revenue: US$1.14m (down 89% from 1Q...
© 2024 Yahoo. All rights reserved.